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Objective: AKI is a major clinical problem and predictor of prognosis in
critically ill patients, whatever any new definitions was used. Our study was to
determine if the new Cys-C (Cystatin C) criteria for identification and short-
term prognosis of AKI was superior to the previous RIFLE (Risk, Injury, Failure,
Loss of kidney function, and End-stage renal failure), AKIN (Acute Kidney Injury
Network), and Kidney Disease: Improving Global Outcomes (KDIGO) criteria.
Methods: A cohort of 4642 patients admitted to five intensive care units (ICUs)
was analyzed in this retrospective and multicenter study. AKI occurring during
whole ICU stay was identified by the RIFLE, AKIN, KDIGO and Cys-C criteria,
and discriminative ability of each AKI stage for the prediction of 28-day mor-
tality was assessed. Receiver operating curve (ROC) were applied to compare
the predictive ability for mortality, and logistic regression analysis was used
for the calculation of odds ratios (OR) and 95% confidence intervals (CI).
Results: In the 1036 patients enrolled, the incidences of AKI were 26.4%, 34.1%,
37.8% and 36.1%, respectively, under the RIFLE, AKIN, KDIGO and Cys-C criteria.
Patients with AKI had highermortality and longer length of stay in ICU than those
without in all definitions. Concordance in AKI diagnosis betweenCys-CandKDIGO
criteriawas 95.9%, higher thanAKINandRIFLE criteria (p< 0.0001). Theareas un-
der the ROC curves were 0.7016 for RIFLE, 0.6934 for AKIN, 0.7013 for KDIGO,
and0.7023 for theCys-C criteria (p< 0.05 forall). Cys-C criteriawere significantly
greater discrimination than the other three criteria (p < 0.05).
Conclusion: KDIGO criteria identified significantly more AKI than RIFLE or
AKIN or Cys-C criteria. The mortality of AKI had significantly higher than
no-AKI patients according to all four criteria. The new Cys-C criteria were
more excellent than the other three criteria in predicting short-term out-
comes in critically ill patients.Figure 1. Receiver operating characteristic (ROC) curve and the discrimi-
natory power for mortality in critically ill patients for the RIFLE, AKIN,
KDIGO, and Cys-C criteria.http://dx.doi.org/10.1016/j.hkjn.2015.09.0750272
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Objective: To investigate the effect of blood perfusion (HP) in the treatment
of acute poisoning and its clinical effect.Methods: The clinical data of 86 patients with oral poisoning were retrospec-
tively analyzed. The patients were divided into HP treatment group (45 cases)
and conventional treatment group without HP treatment (41 cases). All pa-
tients were given gastric lavage treatment. The HP treatment group patients
were given routine coagulation tests. According to these results the first time
administration dosage of heparin was determined as 0.5e1.0 mg/kg, and
additional dosage was 10e20 mg/h. At the same time pay attention to moni-
toring the blood coagulation and platelets, blood flow velocity was set at
150e180 ml/min, and activated carbon canister was replaced every 2 hours,
and repeated blood perfusion treatment on severe poisoning patients. Two
groups of patients were both given conventional drug treatment.
Results: Compared to the control group, the cholinesterase activity recovery
time and length of hospital stay in HP group were significantly shorter
(P < 0.05), but because of the application of heparin, 8 patients in HP group
had transient coagulation disorders, which recovered without special
treatment.
Conclusion: HP in the treatment of all kinds of poisoning curative effect can be
significantly reduced the number of days hospitalized patients and reduce the
mortality of patients, some poisoning patients with no specific antidote, in
treatment shows unique advantages, can significantly improve the success
rate of rescue.http://dx.doi.org/10.1016/j.hkjn.2015.09.0760295
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Objective: Liver X receptors (LXRs) are in the nuclear receptor superfamily and
are contained in the regulation of lipid and cholesterol metabolism. Besides,
LXRs are considered crucial regulators of the inflammatory response and innate
immunity. The current study evaluates the in vivo effects that the synthetic LXR
agonist TO901317 protects against cisplatin-induced kidney injury in mice.
Methods: Mice received cisplatin administration through a single intraperito-
neal (ip) injection (20 mg/kg in saline). And then the mice were treated with
TO901317 by daily gavage (10 mg/kg/d) 12 hours post cisplatin administra-
tion and cisplatin nephrotoxicity was evaluated.
Results: At 72 hours after cisplatin treatment, elevated plasma urea and
creatinine levels (P < 0.05) were evidenced which indicates the renal
dysfunction of the vehicle treated mice, consistent with tubular necrosis,
protein cast, dilation of renal tubules, and desquamation of epithelial cells
in renal tubules. In contrast, the severity of renal dysfunction and histolog-
ical damage was reduced in TO901317 treated mice (P < 0.05). In accor-
dance, circulating tumor necrosis factor alpha (TNF-a) levels, renal TNF-a,
p47phox, gp91phox, and protein expression levels and COX-2 mRNA, renal
MCP-1, VACAM-1 mRNA and ICAM-1 contents, and renal PGE2 amounts,
were higher in samples from cisplatin treated mice in comparison with con-
trols (P < 0.05), but attenuated in the TO901317 treatment group (P < 0.05).
Conclusion: Taken together, treatment with the LXR agonist TO901317
ameliorated the inflammatory response and oxidative stress in cisplatin-
induced kidney injury in mice.http://dx.doi.org/10.1016/j.hkjn.2015.09.0770300
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